ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Faron stock falls on traumakine failure
pharmatimes
July 09, 2018Shares Finnish group Faron Pharmaceuticals were trading down more than 80 percent on the London Stock Exchange after its key drug traumakine failed in acute respiratory distress syndrome (ARDS).
Pharma Sources Insight January 2025
